UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid

Clinical infectious diseases, 2020-08, Vol.71 (4), p.982-988

2020

Volltextzugriff (PDF)

Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir

Clinical infectious diseases, 2021-05, Vol.72 (10), p.1823-1825

Morse, Gene D

2021

Volltextzugriff (PDF)

HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus

The Journal of clinical investigation, 2020-11, Vol.130 (11), p.5847-5857

2020

Volltextzugriff (PDF)

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial

Clinical infectious diseases, 2022-10, Vol.75 (8), p.1389-1396

2022

Volltextzugriff (PDF)

Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus

Clinical infectious diseases, 2023-09, Vol.77 (6), p.866-874

2023

Volltextzugriff (PDF)

Detection of Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy

Clinical infectious diseases, 2008-08, Vol.47 (3), p.421-424

2008

Volltextzugriff (PDF)

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

Journal of antimicrobial chemotherapy, 2014-08, Vol.69 (8), p.2175-2182

2014

Volltextzugriff (PDF)

Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy

The Journal of infectious diseases, 2020-07, Vol.222 (4), p.601-610

2020

Volltextzugriff (PDF)

Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial

Journal of the International AIDS Society, 2020-12, Vol.23 (12), p.e25641-n/a

2020

Volltextzugriff (PDF)

Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage

The Journal of infectious diseases, 2018-01, Vol.217 (3), p.474-482

2018

Volltextzugriff (PDF)

Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s

Journal of antimicrobial chemotherapy, 2017-07, Vol.72 (7), p.2042-2048

2017

Volltextzugriff (PDF)

Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy

Journal of antimicrobial chemotherapy, 2014-05, Vol.69 (5), p.1370-1376

2014

Volltextzugriff (PDF)

Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202

Journal of antimicrobial chemotherapy, 2014-12, Vol.69 (12), p.3300-3310

2014

Volltextzugriff (PDF)

Advances in pharmacogenomics of antiretrovirals: an update

Pharmacogenomics, 2007-09, Vol.8 (9), p.1169-1178

2007

Volltextzugriff (PDF)

2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex: A Phase I Trial

The New England journal of medicine, 1990-05, Vol.322 (19), p.1333-1340

1990

Volltextzugriff (PDF)

Pilot Study of a Novel Short-Cycle Antiretroviral Treatment Interruption Strategy: 48-Week Results of the Five-Days-On, Two-Days-Off (FOTO) Study

HIV clinical trials, 2007-01, Vol.8 (1), p.19-23

2007

Volltextzugriff (PDF)

Drug Interactions with Antiretrovirals

Current infectious disease reports, 2000-06, Vol.2 (3), p.257-266

Morse, GD

2000

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1-Infected Adults With Virologic Suppression on a Protease Inhibitor-Containing Regimen

HIV clinical trials, 2010-12, Vol.11 (6), p.312-324

2010

Volltextzugriff (PDF)

A Randomized Clinical Trial Evaluating Therapeutic Drug Monitoring (TDM) for Protease Inhibitor-Based Regimens in Antiretroviral-Experienced HIV-Infected Individuals: Week 48 Results of the A5146 Study

HIV clinical trials, 2011-07, Vol.12 (4), p.201-214

2011

Volltextzugriff (PDF)

Tutorial Reduces Protocol Deviations in Multicenter ACTG Trials with Pharmacology Endpoints

HIV clinical trials, 2006-07, Vol.7 (4), p.203-209

2006

Volltextzugriff (PDF)

The Design and Implementation of A5146, a Prospective Trial Assessing the Utility of Therapeutic Drug Monitoring Using an Inhibitory Quotient in Antiretroviral-Experienced HIV-Infected Patients

HIV clinical trials, 2008-01, Vol.9 (1), p.61-72

2008

Volltextzugriff (PDF)

Phase I Study of Atevirdine, a Nonnucleoside Reverse Transcriptase Inhibitor, in Combination with Zidovudine for Human Immunodeficiency Virus Type 1 Infection

The Journal of infectious diseases, 1995-02, Vol.171 (2), p.297-304

1995

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaBiological And Medical Sciences

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid

Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir

HIV-1 viremia not suppressible by antiretroviral therapy can originate from large T cell clones producing infectious virus

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial

Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus

Detection of Nonnucleoside Reverse-Transcriptase Inhibitor-Resistant HIV-1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy

Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes

Intrahepatic Viral Kinetics During Direct-Acting Antivirals for Hepatitis C in Human Immunodeficiency Virus Coinfection: The AIDS Clinical Trials Group A5335S Substudy

Effectiveness of a psychological intervention delivered by general nurses for alcohol use disorders in people living with HIV in Zimbabwe: a cluster randomized controlled trial

Hepatic Pharmacokinetics and Pharmacodynamics With Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir Treatment and Variable Ribavirin Dosage

Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s

Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy

Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202

Advances in pharmacogenomics of antiretrovirals: an update

2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex: A Phase I Trial

Pilot Study of a Novel Short-Cycle Antiretroviral Treatment Interruption Strategy: 48-Week Results of the Five-Days-On, Two-Days-Off (FOTO) Study

Drug Interactions with Antiretrovirals

A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1-Infected Adults With Virologic Suppression on a Protease Inhibitor-Containing Regimen

A Randomized Clinical Trial Evaluating Therapeutic Drug Monitoring (TDM) for Protease Inhibitor-Based Regimens in Antiretroviral-Experienced HIV-Infected Individuals: Week 48 Results of the A5146 Study

Tutorial Reduces Protocol Deviations in Multicenter ACTG Trials with Pharmacology Endpoints

The Design and Implementation of A5146, a Prospective Trial Assessing the Utility of Therapeutic Drug Monitoring Using an Inhibitory Quotient in Antiretroviral-Experienced HIV-Infected Patients

Phase I Study of Atevirdine, a Nonnucleoside Reverse Transcriptase Inhibitor, in Combination with Zidovudine for Human Immunodeficiency Virus Type 1 Infection

Aktive Filter

Suchergebnisse filtern